Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. [electronic resource]
Producer: 20111115Description: 2609-17 p. digitalISSN:- 1528-0020
- Acute Disease
- Adolescent
- Adult
- Aged
- Antilymphocyte Serum -- administration & dosage
- Busulfan -- administration & dosage
- Disease-Free Survival
- Female
- Graft Survival
- Graft vs Host Disease -- prevention & control
- Granulocyte Colony-Stimulating Factor -- pharmacology
- HLA Antigens -- analysis
- Hematopoietic Stem Cell Transplantation -- methods
- Histocompatibility
- Humans
- Infections
- Kaplan-Meier Estimate
- Leukemia -- mortality
- Male
- Middle Aged
- Myelodysplastic Syndromes -- mortality
- Peripheral Blood Stem Cell Transplantation -- methods
- Retrospective Studies
- T-Lymphocytes -- immunology
- Tissue Donors
- Transplantation Conditioning -- methods
- Treatment Outcome
- Vidarabine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.